Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Macfarlane Insider Profile
4 Followers
David Macfarlane, Director at Titan Pharmaceuticals, holds 102.28K shares in Titan Pharmaceuticals (Ticker: TTNP). Most recently, David Macfarlane Bought $80,000 shares of Titan Pharmaceuticals on Sep 25, 2018 for an estimated value of 20.00K.
David Macfarlane has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Macfarlane's holdings
Insider Roles
Director
Roles that David Macfarlane holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 25, 2018 - Sep 25, 2019
Return:-76.80%
The most profitable trade made by David Macfarlane
David Macfarlane's Trading History
List of latest transactions for each holding click on a transaction to see David Macfarlane's performance on stock
You May Also Like
David Macfarlane insider profile FAQ
What is the percentage of profitable transactions made by David Macfarlane?
The percentage of profitable transactions made by David Macfarlane is ―.
What is the average return per transaction made by David Macfarlane?
The average return per transaction made by David Macfarlane is ―.
What stocks does David Macfarlane hold?
David Macfarlane holds: TTNP stocks.
What was David Macfarlane’s latest transaction?
David Macfarlane latest transaction was an Informative Buy of $20.00K.
What was David Macfarlane's most profitable transaction?
David Macfarlane’s most profitable transaction was an Informative Buy of TTNP stock on September 25, 2018. The return on the trade was -76.80%.
What is David Macfarlane's role in Titan Pharmaceuticals?
David Macfarlane's role in Titan Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.